Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 253

1.

Publisher Correction: Sarcoidosis.

Grunewald J, Grutters JC, Arkema EV, Saketkoo LA, Moller DR, Müller-Quernheim J.

Nat Rev Dis Primers. 2019 Jul 16;5(1):49. doi: 10.1038/s41572-019-0107-y.

PMID:
31311930
2.

Sarcoidosis.

Grunewald J, Grutters JC, Arkema EV, Saketkoo LA, Moller DR, Müller-Quernheim J.

Nat Rev Dis Primers. 2019 Jul 4;5(1):45. doi: 10.1038/s41572-019-0096-x. Review. Erratum in: Nat Rev Dis Primers. 2019 Jul 16;5(1):49.

PMID:
31273209
3.

Translation and psychometric properties of the King's Sarcoidosis Questionnaire (KSQ) in German language.

Farin E, Heyduck K, Frye BC, Birring SS, Müller-Quernheim J, Schupp JC.

Health Qual Life Outcomes. 2019 Apr 11;17(1):62. doi: 10.1186/s12955-019-1131-z.

4.

A randomized trial of everolimus-based quadruple therapy vs standard triple therapy early after lung transplantation.

Gottlieb J, Neurohr C, Müller-Quernheim J, Wirtz H, Sill B, Wilkens H, Bessa V, Knosalla C, Porstner M, Capusan C, Strüber M.

Am J Transplant. 2019 Jun;19(6):1759-1769. doi: 10.1111/ajt.15251. Epub 2019 Feb 5.

5.

Psychometric properties of the German version of the Leicester Cough Questionnaire in sarcoidosis.

Schupp JC, Fichtner UA, Frye BC, Heyduck-Weides K, Birring SS, Windisch W, Criée CP, Müller-Quernheim J, Farin E.

PLoS One. 2018 Oct 4;13(10):e0205308. doi: 10.1371/journal.pone.0205308. eCollection 2018.

6.

Kinetics of Torque Teno Virus-DNA Plasma Load Predict Rejection in Lung Transplant Recipients.

Frye BC, Bierbaum S, Falcone V, Köhler TC, Gasplmayr M, Hettich I, Dürk T, Idzko M, Zissel G, Hengel H, Müller-Quernheim J.

Transplantation. 2019 Apr;103(4):815-822. doi: 10.1097/TP.0000000000002436.

PMID:
30234787
7.

Whole-exome sequencing identifies rare genetic variations in German families with pulmonary sarcoidosis.

Kishore A, Petersen BS, Nutsua M, Müller-Quernheim J, Franke A, Fischer A, Schreiber S, Petrek M.

Hum Genet. 2018 Sep;137(9):705-716. doi: 10.1007/s00439-018-1915-y. Epub 2018 Jul 27.

PMID:
30054724
8.

Impact of Lung Function on Bronchiolitis Obliterans Syndrome and Outcome after Allogeneic Hematopoietic Cell Transplantation with Reduced-Intensity Conditioning.

Duque-Afonso J, Ihorst G, Waterhouse M, Zeiser R, Wäsch R, Bertz H, Müller-Quernheim J, Finke J, Marks R, Prasse A.

Biol Blood Marrow Transplant. 2018 Nov;24(11):2277-2284. doi: 10.1016/j.bbmt.2018.06.024. Epub 2018 Jun 28.

PMID:
29964193
9.

Phenotypes of organ involvement in sarcoidosis.

Schupp JC, Freitag-Wolf S, Bargagli E, Mihailović-Vučinić V, Rottoli P, Grubanovic A, Müller A, Jochens A, Tittmann L, Schnerch J, Olivieri C, Fischer A, Jovanovic D, Filipovic S, Videnovic-Ivanovic J, Bresser P, Jonkers R, O'Reilly K, Ho LP, Gaede KI, Zabel P, Dubaniewicz A, Marshall B, Kieszko R, Milanowski J, Günther A, Weihrich A, Petrek M, Kolek V, Keane MP, O'Beirne S, Donnelly S, Haraldsdottir SO, Jorundsdottir KB, Costabel U, Bonella F, Wallaert B, Grah C, Peroš-Golubičić T, Luisetti M, Kadija Z, Pabst S, Grohé C, Strausz J, Vašáková M, Sterclova M, Millar A, Homolka J, Slováková A, Kendrick Y, Crawshaw A, Wuyts W, Spencer L, Pfeifer M, Valeyre D, Poletti V, Wirtz H, Prasse A, Schreiber S, Krawczak M, Müller-Quernheim J.

Eur Respir J. 2018 Jan 25;51(1). pii: 1700991. doi: 10.1183/13993003.00991-2017. Print 2018 Jan.

10.

Correction: Is serum level of CC chemokine ligand 18 a biomarker for the prediction of radiation induced lung toxicity (RILT)?

Gkika E, Vach W, Adebahr S, Schimek-Jasch T, Brenner A, Brunner TB, Kaier K, Prasse A, Müller-Quernheim J, Grosu AL, Zissel G, Nestle U.

PLoS One. 2018 Jan 25;13(1):e0192058. doi: 10.1371/journal.pone.0192058. eCollection 2018.

11.

German Guideline for Idiopathic Pulmonary Fibrosis - Update on Pharmacological Therapies 2017.

Behr J, Günther A, Bonella F, Geißler K, Koschel D, Kreuter M, Prasse A, Schönfeld N, Sitter H, Müller-Quernheim J, Costabel U.

Pneumologie. 2018 Feb;72(2):155-168. doi: 10.1055/s-0043-123035. Epub 2018 Jan 16.

12.

Atopobium and Fusobacterium as novel candidates for sarcoidosis-associated microbiota.

Zimmermann A, Knecht H, Häsler R, Zissel G, Gaede KI, Hofmann S, Nebel A, Müller-Quernheim J, Schreiber S, Fischer A.

Eur Respir J. 2017 Dec 14;50(6). pii: 1600746. doi: 10.1183/13993003.00746-2016. Print 2017 Dec.

13.

Is serum level of CC chemokine ligand 18 a biomarker for the prediction of radiation induced lung toxicity (RILT)?

Gkika E, Vach W, Adebahr S, Schimek-Jasch T, Brenner A, Brunner TB, Kaier K, Prasse A, Müller-Quernheim J, Grosu AL, Zissel G, Nestle U.

PLoS One. 2017 Sep 28;12(9):e0185350. doi: 10.1371/journal.pone.0185350. eCollection 2017. Erratum in: PLoS One. 2018 Jan 25;13(1):e0192058.

14.

Erratum for Maler et al., "Key Role of the Scavenger Receptor MARCO in Mediating Adenovirus Infection and Subsequent Innate Responses of Macrophages".

Maler MD, Nielsen PJ, Stichling N, Cohen I, Ruzsics Z, Wood C, Engelhard P, Suomalainen M, Gyory I, Huber M, Müller-Quernheim J, Schamel WW, Gordon S, Jakob T, Martin SF, Jahnen-Dechent W, Greber UF, Freudenberg MA, Fejer G.

MBio. 2017 Sep 26;8(5). pii: e01445-17. doi: 10.1128/mBio.01445-17. No abstract available.

15.

Key Role of the Scavenger Receptor MARCO in Mediating Adenovirus Infection and Subsequent Innate Responses of Macrophages.

Maler MD, Nielsen PJ, Stichling N, Cohen I, Ruzsics Z, Wood C, Engelhard P, Suomalainen M, Gyory I, Huber M, Müller-Quernheim J, Schamel WWA, Gordon S, Jakob T, Martin SF, Jahnen-Dechent W, Greber UF, Freudenberg MA, Fejer G.

MBio. 2017 Aug 1;8(4). pii: e00670-17. doi: 10.1128/mBio.00670-17. Erratum in: MBio. 2017 Sep 26;8(5):.

16.

Sarcoidosis: Drugs under Investigation.

Schupp JC, Frye BC, Zissel G, Müller-Quernheim J.

Semin Respir Crit Care Med. 2017 Aug;38(4):532-537. doi: 10.1055/s-0037-1603768. Epub 2017 Jul 27. Review. No abstract available.

PMID:
28750466
17.

Influence of lung CT changes in chronic obstructive pulmonary disease (COPD) on the human lung microbiome.

Engel M, Endesfelder D, Schloter-Hai B, Kublik S, Granitsiotis MS, Boschetto P, Stendardo M, Barta I, Dome B, Deleuze JF, Boland A, Müller-Quernheim J, Prasse A, Welte T, Hohlfeld J, Subramanian D, Parr D, Gut IG, Greulich T, Koczulla AR, Nowinski A, Gorecka D, Singh D, Gupta S, Brightling CE, Hoffmann H, Frankenberger M, Hofer TP, Burggraf D, Heiss-Neumann M, Ziegler-Heitbrock L, Schloter M, Zu Castell W.

PLoS One. 2017 Jul 13;12(7):e0180859. doi: 10.1371/journal.pone.0180859. eCollection 2017.

18.

[German Guideline for Idiopathic Pulmonary Fibrosis - Update on Pharmacological Therapies 2017].

Behr J, Günther A, Bonella F, Geißler K, Koschel D, Kreuter M, Prasse A, Schönfeld N, Sitter H, Müller-Quernheim J, Costabel U.

Pneumologie. 2017 Jul;71(7):474. doi: 10.1055/s-0043-115504. Epub 2017 Jul 5. German. No abstract available.

PMID:
28679139
19.

[German Guideline for Idiopathic Pulmonary Fibrosis - Update on Pharmacological Therapies 2017].

Behr J, Günther A, Bonella F, Geißler K, Koschel D, Kreuter M, Prasse A, Schönfeld N, Sitter H, Müller-Quernheim J, Costabel U.

Pneumologie. 2017 Jul;71(7):460-474. doi: 10.1055/s-0043-106160. Epub 2017 May 30. German. Erratum in: Pneumologie. 2017 Jul;71(7):474.

PMID:
28558396
20.

Turning back the Wheel: Inducing Mesenchymal to Epithelial Transition via Wilms Tumor 1 Knockdown in Human Mesothelioma Cell Lines to Influence Proliferation, Invasiveness, and Chemotaxis.

Plönes T, Fischer M, Höhne K, Sato H, Müller-Quernheim J, Zissel G.

Pathol Oncol Res. 2017 Oct;23(4):723-730. doi: 10.1007/s12253-016-0181-3. Epub 2017 Jan 4.

PMID:
28054314
21.

Functional Toll-Like Receptor 9 Expression and CXCR3 Ligand Release in Pulmonary Sarcoidosis.

Schnerch J, Prasse A, Vlachakis D, Schuchardt KL, Pechkovsky DV, Goldmann T, Gaede KI, Müller-Quernheim J, Zissel G.

Am J Respir Cell Mol Biol. 2016 Nov;55(5):749-757.

PMID:
27390897
22.

Insights from the German Compassionate Use Program of Nintedanib for the Treatment of Idiopathic Pulmonary Fibrosis.

Bonella F, Kreuter M, Hagmeyer L, Neurohr C, Keller C, Kohlhaeufl MJ, Müller-Quernheim J, Milger K, Prasse A; German Nintedanib Compassionate Use Consortium.

Respiration. 2016;92(2):98-106. doi: 10.1159/000448288. Epub 2016 Aug 20.

23.

Association Study for 26 Candidate Loci in Idiopathic Pulmonary Fibrosis Patients from Four European Populations.

Kishore A, Žižková V, Kocourková L, Petrkova J, Bouros E, Nunes H, Loštáková V, Müller-Quernheim J, Zissel G, Kolek V, Bouros D, Valeyre D, Petrek M.

Front Immunol. 2016 Jul 11;7:274. doi: 10.3389/fimmu.2016.00274. eCollection 2016.

24.

Emphysema- and airway-dominant COPD phenotypes defined by standardised quantitative computed tomography.

Subramanian DR, Gupta S, Burggraf D, Vom Silberberg SJ, Heimbeck I, Heiss-Neumann MS, Haeussinger K, Newby C, Hargadon B, Raj V, Singh D, Kolsum U, Hofer TP, Al-Shair K, Luetzen N, Prasse A, Müller-Quernheim J, Benea G, Leprotti S, Boschetto P, Gorecka D, Nowinski A, Oniszh K, Castell WZ, Hagen M, Barta I, Döme B, Strausz J, Greulich T, Vogelmeier C, Koczulla AR, Gut I, Hohlfeld J, Welte T, Lavae-Mokhtari M, Ziegler-Heitbrock L, Brightling C, Parr DG.

Eur Respir J. 2016 Jul;48(1):92-103. doi: 10.1183/13993003.01878-2015. Epub 2016 May 26.

25.

[Sarcoidosis].

Frye BC, Schupp JC, Köhler TC, Voll RE, Müller-Quernheim J.

Z Rheumatol. 2016 May;75(4):389-401. doi: 10.1007/s00393-016-0086-2. Review. German.

PMID:
27146405
26.

Usefulness of Cyclophosphamide Pulse Therapy in Interstitial Lung Diseases.

Schupp JC, Köhler T, Müller-Quernheim J.

Respiration. 2016;91(4):296-301. doi: 10.1159/000445031. Epub 2016 Apr 16.

27.

[Case Report with Differential Diagnostic Aspects of Sarcoidosis].

Baur X, Müller-Quernheim J.

Pneumologie. 2016 Mar;70(3):201-4. doi: 10.1055/s-0042-101661. Epub 2016 Mar 15. German.

PMID:
26977753
28.

[New Pathogenetic Concepts and Early Pharmacological Studies in Sarcoidosis].

Schupp JC, Frye BC, Zissel G, Müller-Quernheim J.

Pneumologie. 2016 Apr;70(4):231-40. doi: 10.1055/s-0041-108311. Epub 2016 Mar 3. Review. German.

PMID:
26937647
29.

Specific antigen(s) in sarcoidosis: a link to autoimmunity?

Zissel G, Müller-Quernheim J.

Eur Respir J. 2016 Mar;47(3):707-9. doi: 10.1183/13993003.01791-2015. No abstract available.

30.

[Erratum to: Diagnosis and treatment of sarcoidosis. Current standards].

Frye BC, Schupp JC, Köhler TC, Müller-Quernheim J.

Internist (Berl). 2016 Jan;57(1):37. doi: 10.1007/s00108-015-3855-0. German. No abstract available.

PMID:
26678285
31.

High-Density Genetic Mapping Identifies New Susceptibility Variants in Sarcoidosis Phenotypes and Shows Genomic-driven Phenotypic Differences.

Rivera NV, Ronninger M, Shchetynsky K, Franke A, Nöthen MM, Müller-Quernheim J, Schreiber S, Adrianto I, Karakaya B, van Moorsel CH, Navratilova Z, Kolek V, Rybicki BA, Iannuzzi MC, Petrek M, Grutters JC, Montgomery C, Fischer A, Eklund A, Padyukov L, Grunewald J.

Am J Respir Crit Care Med. 2016 May 1;193(9):1008-22. doi: 10.1164/rccm.201507-1372OC.

32.

Cellular Players in the Immunopathogenesis of Sarcoidosis.

Zissel G, Müller-Quernheim J.

Clin Chest Med. 2015 Dec;36(4):549-60. doi: 10.1016/j.ccm.2015.08.016. Review.

PMID:
26593132
33.

[Diagnosis and treatment of sarcoidosis. Current standards].

Frye BC, Schupp JC, Köhler TL, Müller-Quernheim J.

Internist (Berl). 2015 Dec;56(12):1346-52. doi: 10.1007/s00108-015-3757-1. German. Erratum in: Internist (Berl). 2016 Jan;57(1):37.

PMID:
26563335
34.

Are bronchoalveolar lavages a good source for microbial profiling? Differences between throat and bronchoalveolar lavage microbiomes.

Zimmermann A, Zissel G, Müller-Quernheim J, Hofmann S, Schreiber S, Fischer A.

J Med Microbiol. 2015 Aug;64(8):948-951. doi: 10.1099/jmm.0.000112. No abstract available.

PMID:
26271248
35.

[Position Paper: Significance of the Forced Vital Capacity in Idiopathic Pulmonary Fibrosis].

Behr J, Bonella F, Bonnet R, Gläser S, Grohé C, Günther A, Koschel D, Kreuter M, Kirsten D, Krögel C, Markart P, Müller-Quernheim J, Neurohr C, Pfeifer M, Prasse A, Schönfeld N, Schreiber J, Wirtz H, Witt C, Costabel U.

Pneumologie. 2015 Aug;69(8):455-8. doi: 10.1055/s-0034-1392602. Epub 2015 Jul 30. German.

36.

Immune response to Propionibacterium acnes in patients with sarcoidosis--in vivo and in vitro.

Schupp JC, Tchaptchet S, Lützen N, Engelhard P, Müller-Quernheim J, Freudenberg MA, Prasse A.

BMC Pulm Med. 2015 Jul 24;15:75. doi: 10.1186/s12890-015-0070-7.

37.

In memoriam Prof. Dr. Rudolf Ferlinz.

Müller-Quernheim J.

Pneumologie. 2015 Jun;69(6):371. doi: 10.1055/s-0034-1392248. Epub 2015 Jun 11. German. No abstract available.

PMID:
26069098
38.

Identification of Immune-Relevant Factors Conferring Sarcoidosis Genetic Risk.

Fischer A, Ellinghaus D, Nutsua M, Hofmann S, Montgomery CG, Iannuzzi MC, Rybicki BA, Petrek M, Mrazek F, Pabst S, Grohé C, Grunewald J, Ronninger M, Eklund A, Padyukov L, Mihailovic-Vucinic V, Jovanovic D, Sterclova M, Homolka J, Nöthen MM, Herms S, Gieger C, Strauch K, Winkelmann J, Boehm BO, Brand S, Büning C, Schürmann M, Ellinghaus E, Baurecht H, Lieb W, Nebel A, Müller-Quernheim J, Franke A, Schreiber S; GenPhenReSa Consortium.

Am J Respir Crit Care Med. 2015 Sep 15;192(6):727-36. doi: 10.1164/rccm.201503-0418OC.

39.

Macrophage activation in acute exacerbation of idiopathic pulmonary fibrosis.

Schupp JC, Binder H, Jäger B, Cillis G, Zissel G, Müller-Quernheim J, Prasse A.

PLoS One. 2015 Jan 15;10(1):e0116775. doi: 10.1371/journal.pone.0116775. eCollection 2015.

40.

An official American Thoracic Society statement: diagnosis and management of beryllium sensitivity and chronic beryllium disease.

Balmes JR, Abraham JL, Dweik RA, Fireman E, Fontenot AP, Maier LA, Muller-Quernheim J, Ostiguy G, Pepper LD, Saltini C, Schuler CR, Takaro TK, Wambach PF; ATS Ad Hoc Committee on Beryllium Sensitivity and Chronic Beryllium Disease.

Am J Respir Crit Care Med. 2014 Nov 15;190(10):e34-59. doi: 10.1164/rccm.201409-1722ST. Review.

PMID:
25398119
41.

Genetics of sarcoidosis.

Fischer A, Grunewald J, Spagnolo P, Nebel A, Schreiber S, Müller-Quernheim J.

Semin Respir Crit Care Med. 2014 Jun;35(3):296-306. doi: 10.1055/s-0034-1376860. Epub 2014 Jul 9. Review.

PMID:
25007082
42.

"Sarcoidosis: recent advances".

Müller-Quernheim J, Prasse A, Moller DR.

Semin Respir Crit Care Med. 2014 Jun;35(3):283-4. doi: 10.1055/s-0034-1376864. Epub 2014 Jul 9. No abstract available.

PMID:
25007080
43.

Serum CCL18 is predictive for lung disease progression and mortality in systemic sclerosis.

Schupp J, Becker M, Günther J, Müller-Quernheim J, Riemekasten G, Prasse A.

Eur Respir J. 2014 May;43(5):1530-2. doi: 10.1183/09031936.00131713. No abstract available.

44.

["Physicians/Managers 2013": a study of the German Society of Internal Medicine].

Fölsch UR, Märker-Hermann E, Schumm-Draeger PM, Frey N, Müller-Quernheim J, Stüber E, Weber M, Broglie M, Kapitza T.

Dtsch Med Wochenschr. 2014 Apr;139(14):726-34. doi: 10.1055/s-0034-1369904. Epub 2014 Mar 25. German. No abstract available. Erratum in: Dtsch Med Wochenschr. 2014 Apr;139(14):e10. Märker-Hemann, E [corrected to Märker-Hermann, E].

PMID:
24668437
45.

[Cardiac sarcoidosis: diagnostic and therapeutic algorithms].

Costabel U, Skowasch D, Pabst S, Störk S, Tschöpe C, Allewelt M, Worth H, Müller-Quernheim J, Grohé C.

Pneumologie. 2014 Feb;68(2):124-32. doi: 10.1055/s-0033-1359197. Epub 2014 Feb 4. German.

46.

Lung collagens perpetuate pulmonary fibrosis via CD204 and M2 macrophage activation.

Stahl M, Schupp J, Jäger B, Schmid M, Zissel G, Müller-Quernheim J, Prasse A.

PLoS One. 2013 Nov 20;8(11):e81382. doi: 10.1371/journal.pone.0081382. eCollection 2013.

47.

[Genetic risk profile of sarcoidosis].

Fischer A, Zissel G, Nebel A, Müller-Quernheim J.

Internist (Berl). 2014 Feb;55(2):135-40. doi: 10.1007/s00108-013-3308-6. German.

PMID:
24217528
48.

Sarcoidosis.

Valeyre D, Prasse A, Nunes H, Uzunhan Y, Brillet PY, Müller-Quernheim J.

Lancet. 2014 Mar 29;383(9923):1155-67. doi: 10.1016/S0140-6736(13)60680-7. Epub 2013 Oct 1. Review.

PMID:
24090799
49.

[Granulomatous lung and systemic diseases].

Prasse A, Kayser G, Müller-Quernheim J.

Internist (Berl). 2013 Apr;54(4):416-25. doi: 10.1007/s00108-012-3187-2. German.

PMID:
23463460
50.

[Health surveillance for workers exposed to beryllium and diagnostic procedures in beryllium-associated diseases].

Euler U, Dahmann D, Follmann M, Gaede KI, Gäßler A, Groneberg D, Heger M, Krutz K, Latza U, Lelgemann M, Letzel S, Merget R, Müller-Quernheim J, Nauert T, Seidler A; Deutsche Gesellschaft für Arbeitsmedizin und Umweltmedizin e. V.

Dtsch Med Wochenschr. 2013 Mar;138(10):488-92. doi: 10.1055/s-0032-1332900. Epub 2013 Feb 26. German. No abstract available.

PMID:
23444026

Supplemental Content

Loading ...
Support Center